In God and CAM We Trust. Religious Faith and Use of Complementary and Alternative Medicine (CAM) in a Nationwide Cohort of Women Treated for Early Breast Cancer

被引:19
|
作者
Pedersen, Christina Gundgaard [1 ,2 ]
Christensen, Soren [1 ,2 ]
Jensen, Anders Bonde [3 ]
Zachariae, Robert [1 ,2 ]
机构
[1] Aarhus Univ Hosp, Unit Psychooncol & Hlth Psychol, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ, DK-8000 Aarhus C, Denmark
[3] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
关键词
Breast cancer; Faith; complementary and alternative medicine; Cam; Prevalence; HEALTH; SPIRITUALITY; ILLNESS; COMORBIDITY; POPULATION; MORTALITY; INTERVIEW; SURVIVORS; PEOPLE; ADULTS;
D O I
10.1007/s10943-012-9569-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Turning to faith in God or a higher spiritual power is a common way of coping with life-threatening disease such as cancer. Little, however, is known about religious faith among cancer patients in secular societies. The present study aimed at exploring the prevalence of religious faith among Danish breast cancer patients and at identifying whether socio-demographic, pre-cancer health status, clinical, and health behavior characteristics, including their use of complementary and alternative medicine (CAM), were associated with their degree of faith. Information on faith in God or a higher spiritual power and use of CAM was provided by a nationwide sample of 3,128 recurrence-free Danish women who had received surgery for early-stage breast cancer 15-16 months earlier. Socio-demographic, clinical, and health status variables were obtained from national longitudinal registries, and health behaviors had been assessed at 3-4 months post-surgery. Of the women, 47.3% reported a high degree of faith (unambiguous believers), 35.9% some degree of faith (ambiguous believers), while the remaining 16.8% were non-believers. Unambiguous believers were more likely than ambiguous believers to experience their faith as having a positive impact on their disease and their disease-related quality-of-life. When compared to non-believers, unambiguous believers were also older, had poorer physical function, and were more frequent users of CAM, and more inclined to believe that their use of CAM would have a beneficial influence on their cancer. Disease- and treatment-related variables were unrelated to faith. While overall religious faith appears equally prevalent among Danish and US breast cancer patients, the majority of Danish breast cancer patients experienced ambiguous faith, whereas the majority of US patients have been found to express unambiguous faith. Our results suggest that future studies may benefit from exploring the role of faith for health behaviors, adherence to conventional treatment, and impact upon quality of life.
引用
收藏
页码:991 / 1013
页数:23
相关论文
共 50 条
  • [41] Development and Validation of an Instrument for Measuring Attitudes and Beliefs about Complementary and Alternative Medicine (CAM) Use among Cancer Patients
    Mao, Jun J.
    Palmer, Steve C.
    Desai, Krupali
    Li, Susan Q.
    Armstrong, Katrina
    Xie, Sharon X.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [42] The Use of Complementary and Alternative Medicine by Korean Breast Cancer Women: Is It Associated with Severity of Symptoms?
    Hwang, Jung Hye
    Kim, Woon-Yong
    Ahmed, Mansoor
    Choi, Soojeung
    Kim, Jiwoo
    Han, Dong Woon
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [43] High use of complementary and alternative medicine among a large cohort of women with a family history of breast cancer: the Sister Study
    Heather Greenlee
    Christine L. Sardo Molmenti
    Laura Falci
    Ross Ulmer
    Sandra Deming-Halverson
    Lisa A. DeRoo
    Dale P. Sandler
    Breast Cancer Research and Treatment, 2016, 156 : 527 - 538
  • [44] Complementary and Alternative Medicine Use, Spending, and Quality of Life in Early Stage Breast Cancer
    Wyatt, Gwen
    Sikorskii, Alla
    Wills, Celia E.
    An, Hong Su
    NURSING RESEARCH, 2010, 59 (01) : 58 - 66
  • [45] Use of Complementary and Alternative Medicine Among Newly Diagnosed Breast Cancer Patients in Malaysia: An Early Report From the MyBCC Study
    Zulkipli, Aina Farhana
    Islam, Tania
    Taib, Nur Aishah Mohd
    Dahlui, Maznah
    Bhoo-Pathy, Nirmala
    Al-Sadat, Nabilla
    Majid, Hazreen Abdul
    Hussain, Samsinah
    INTEGRATIVE CANCER THERAPIES, 2018, 17 (02) : 312 - 321
  • [46] Awareness, Use and Outlook of Complementary and Alternative Medicine (CAM) Options in an Underserved, Uninsured Minority Cancer Patient Population
    Bari, Shahla
    Chineke, Iloabueke
    Darwin, Alicia
    Umar, Anam
    Jim, Heather
    Muzaffar, Jameel
    Kucuk, Omer
    INTEGRATIVE CANCER THERAPIES, 2021, 20
  • [47] Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey
    Joshua Bauml
    Corey J. Langer
    Tracey Evans
    Sheila N. Garland
    Krupali Desai
    Jun J. Mao
    Supportive Care in Cancer, 2014, 22 : 2465 - 2472
  • [48] Utilization of complementary and alternative medicine (CAM) among children from a German birth cohort (GINIplus): patterns, costs, and trends of use
    Salvatore Italia
    Helmut Brand
    Joachim Heinrich
    Dietrich Berdel
    Andrea von Berg
    Silke Britta Wolfenstetter
    BMC Complementary and Alternative Medicine, 15
  • [49] Utilization of complementary and alternative medicine (CAM) among children from a German birth cohort (GINIplus): patterns, costs, and trends of use
    Italia, Salvatore
    Brand, Helmut
    Heinrich, Joachim
    Berdel, Dietrich
    von Berg, Andrea
    Wolfenstetter, Silke Britta
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
  • [50] Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002
    Bauer, Nina
    Kairey, Lana
    Schlee, Christoph
    Uecker, Christine
    Oeznur, Oezlem
    Langhorst, Jost
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (10) : 1209 - 1215